Tavapadon success news

[Farooqji]

I am astonished why no one here has noted the biggest headline of today's news papers about the Tavapadon success in PD

[park_bear]

It might be a better dopamine agonist: "Tavapadon is the first and only D1/D5 partial agonist under investigation as a once-daily treatment for Parkinson's disease." After approval it will be interesting to see what the actual adverse effects are.

[Fed1000]

Great news! Only for early Parkinson’s?

[Apollo84 in reply to Fed1000]

I was in one of the multiple studies and having PD for over five years. It was a game changer for me personally. I was 90% ON with minimal C/L supplementing needed. When the study was over, February 2023, I realized how good the drug had worked. No other drug combinations came close to the results I was having. I’ve written and emailed the company multiple times to try to get access to the drug again, put was told I couldn’t until the drug was approved by the FDA.

[Fed1000 in reply to Apollo84]

This is the news we like. Let's hope they do it soon. Thank you very much

[nednedned in reply to Apollo84]

Have you tried old school agonists? How does it compare to them?

[Despe in reply to Fed1000]

Good question! I was wondering about that, too. Early diagnosis: 1, 2, 3, 4, 5 years? What is considered early diagnosis?

[gomelgo]

how long do you think it will to be approved?

[Bungalow31]

I read they are on time for approval in 2025. I love some optimism with this disease because usually there isn’t any. I believe there are lots of clinical trials coming to fruition with good results. I pray sooner than I